Triptorelin - Immune System Regulation

Drug Profile

Triptorelin - Immune System Regulation

Alternative Names: ISR-48

Latest Information Update: 27 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Immune System Regulation
  • Class Antineoplastics; Antivirals; Infertility therapies; Oligopeptides; Pituitary hormone releasing hormones
  • Mechanism of Action Gonadotropin releasing hormone stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II HIV-1 infections
  • Preclinical Herpes simplex virus infections

Most Recent Events

  • 15 Mar 2018 Phase-II clinical trials in HIV-1 infections (Combination therapy, Treatment experienced) in Sweden (EudraCT2017-004160-35)
  • 12 Jan 2018 The Swedish Medicines Agency approves a clinical trial application for a phase IIa trial for triptorelin in HIV-1 infections
  • 01 Dec 2017 Preclinical trials in Herpes simplex virus infections in Sweden
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top